Persistent genital arousal disorder: Successful treatment with duloxetine and pregabalin in two cases

Journal of Sexual Medicine

Volumn 9, Issue 1, 2012, Pages 213-217

  Philippsohn, Susanne ^a   Kruger, Tillmann H C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Duloxetine; Persistent Genital Arousal Disorder; Persistent Sexual Arousal Syndrome; PGAD; Pregabalin; Restless Genital Syndrome; Unwanted Genital Arousal

Indexed keywords

AMITRIPTYLINE; CLONAZEPAM; DULOXETINE; PREGABALIN; QUETIAPINE;

ADULT; ARTICLE; CASE REPORT; CLITORIS; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; GENITAL PAIN; HUMAN; ORGASM; OUTCOME ASSESSMENT; PERSISTENT GENITAL AROUSAL DISORDER; PRIORITY JOURNAL; REMISSION; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SLEEP DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY URGENCY;

EID: 84855348377     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02518.x     Document Type: Article

References (18)

1. Modell JG. Repeated observations of yawning, clitoral engorgement, and orgasm associated with fluoxetine administration. J Clin Psychopharmacol 1989;9:63-5.
2. Leiblum SR, Nathan SG. Persistent sexual arousal syndrome: A newly discovered pattern of female sexuality. J Sex Marital Ther 2001;27:365-80.
3. Goldmeier D, Mears A, Hiller J, Crowley T. Persistent genital arousal disorder: A review of the literature and recommendations for management. Int J STD AIDS 2009;20:373-7.
4. Waldinger MD, de Lint GJ, Venema PL, van Gils AP, Schweitzer DH. Successful transcutaneous electrical nerve stimulation in two women with restless genital syndrome: The role of adelta- and C-nerve fibers. J Sex Med 2010;7:1190-9.
5. Brotto LA, Bitzer J, Laan E, Leiblum S, Luria M. Women's sexual desire and arousal disorders. J Sex Med 2010;7:586-614.
6. Rosenbaum TY. Physical therapy evaluation of dyspareunia. In: Goldstein AT, Pukall CF, Goldstein I, eds. Female sexual pain disorders: Evaluation and management. Oxford: Wiley-Blackwell Publishing; 2009:27-31.
7. Rosenbaum TY. Physical therapy treatment of persistent genital arousal disorder during pregnancy: A case report. J Sex Med 2010;7:1306-10.
8. Leiblum S, Seehuus M, Goldmeier D, Brown C. Psychological, Medical, and Pharmacological Correlates of Persistent Genital Arousal Disorder. J Sex Med 2007;4:1358-66.
9. Leiblum SR, Chivers ML. Normal and persistent genital arousal in women: New perspectives. J Sex Marital Ther 2007;33:357-73.
10. Waldinger MD, Schweitzer DH. Persistent genital arousal disorder in 18 Dutch women: Part II. A syndrome clustered with restless legs and overactive bladder. J Sex Med 2009;6:482-97.
11. Waldinger MD, Venema PL, van Gils AP, Schweitzer DH. New insights into restless genital syndrome: Static mechanical hyperesthesia and neuropathy of the nervus dorsalis clitoridis. J Sex Med 2009;6:2778-87.
12. Bellingham GA, Peng PW. Duloxetine: A review of its pharmacology and use in chronic pain management. Reg Anesth Pain Med 2010;35:294-303.
13. Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007;4:917-29.
14. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506-33.
15. Korda JB, Pfaus JG, Kellner CH, Goldstein I. Persistent genital arousal disorder (PGAD): Case report of long-term symptomatic management with electroconvulsive therapy. J Sex Med 2009;6:2901-9.
16. Boy S, Reitz A, Wirth B, Knapp PA, Braun PM, Haferkamp A, Schurch B. Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: A functional urodynamic study in healthy women. Eur Urol 2006;50:119-25.
17. Jost W, Marsalek P. Duloxetine: Mechanism of action at the lower urinary tract and Onuf's nucleus. Clin Auton Res 2004;14:220-7.
18. Bauer CS, Rahman W, Tran-van-Minh A, Lujan R, Dickenson AH, Dolphin AC. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans 2010;38:525-8.